SEC Filing | Abbott Laboratories

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Szela Mary T

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK

60064-6400

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2007

3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Senior Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	71,101	D
Common shares without par value	7,823⁽¹⁾	I	Profit Sharing Trust

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)⁽²⁾	02/12/2000	02/11/2009	Common shares	1	42.5	D
Option (right to buy)⁽²⁾	02/12/2001	02/11/2009	Common shares	322	42.5	D
Option (right to buy)⁽²⁾	02/12/2002	02/11/2009	Common shares	2,353	42.5	D
Option (right to buy)⁽²⁾	02/11/2003	02/11/2010	Common shares	2,488	32.61	D
Option (right to buy)⁽²⁾	02/09/2002	02/08/2011	Common shares	6,277	45.45	D
Option (right to buy)⁽²⁾	02/09/2003	02/08/2011	Common shares	6,278	45.45	D
Option (right to buy)⁽²⁾	02/09/2004	02/08/2011	Common shares	6,278	45.45	D
Option (right to buy)⁽²⁾	06/01/2002	05/31/2011	Common shares	5,320	48.12	D
Option (right to buy)⁽²⁾	06/01/2003	05/31/2011	Common shares	5,320	48.12	D
Option (right to buy)⁽²⁾	06/01/2004	05/31/2011	Common shares	5,320	48.12	D
Option (right to buy)⁽²⁾	04/16/2002	10/14/2011	Common shares	133	48.79	D
Option (right to buy)⁽²⁾	02/15/2003	02/14/2012	Common shares	17,734	53.63	D
Option (right to buy)⁽²⁾	02/15/2004	02/14/2012	Common shares	17,734	53.63	D
Option (right to buy)⁽²⁾	02/15/2005	02/14/2012	Common shares	17,733	53.63	D
Option (right to buy)⁽²⁾	11/02/2002	02/10/2010	Common shares	57	50.7	D
Option (right to buy)⁽²⁾	12/06/2003	02/10/2010	Common shares	447	41.97	D
Option (right to buy)⁽²⁾	02/20/2006	02/19/2014	Common shares	10,604	41.03	D
Option (right to buy)⁽²⁾	02/20/2007	02/19/2014	Common shares	10,639	41.03	D
Option (right to buy)⁽³⁾	02/18/2006	02/17/2015	Common shares	11,600	46.34	D
Option (right to buy)⁽³⁾	02/18/2007	02/17/2015	Common shares	11,600	46.34	D
Option (right to buy)⁽³⁾	02/18/2008	02/17/2015	Common shares	11,600	46.34	D
Option (right to buy)⁽³⁾	11/06/2005	02/13/2013	Common shares	928	49.71	D
Option (right to buy)⁽³⁾	07/01/2006	02/13/2013	Common shares	1,158	43	D
Option (right to buy)⁽³⁾	02/17/2007	02/16/2016	Common shares	12,000	44.16	D
Option (right to buy)⁽³⁾	02/17/2008	02/16/2016	Common shares	12,000	44.16	D
Option (right to buy)⁽³⁾	02/17/2009	02/16/2016	Common shares	12,000	44.16	D
Option (right to buy)⁽³⁾	02/19/2006	02/13/2013	Common shares	2,620	49.13	D
Option (right to buy)⁽³⁾	02/16/2008	02/15/2017	Common shares	11,900	52.54	D
Option (right to buy)⁽³⁾	02/16/2009	02/15/2017	Common shares	11,900	52.54	D

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of August 27, 2007.

2. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

3. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

Form 1 of 2

	Deborah K. Koenen, by power of attorney for Mary T. Szela	09/06/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.